Who Owns Alamar Biosciences Stock?
NASDAQ: ALMRIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 58.91%
- Held by insiders
- 22.29%
- Institutional holders
- 142
- Institutions 58.9%
- Insiders 22.3%
- Public and other 18.8%
Who owns Alamar Biosciences stock?
Institutional investors own about 58.9% of Alamar Biosciences's shares, spread across 142 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 22.29% of ALMR.
The largest institutional holders are Sands Capital Alternatives, LLC (6.09%), Samsara BioCapital, LLC (3.57%) and T. Rowe Price Investment Management, Inc. (3.17%). Together, the top 10 institutions control 22.9% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their ALMR positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ALMR
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Sands Capital Alternatives, LLC | 4.23M | 6.09% | 0.0% |
| Samsara BioCapital, LLC | 2.48M | 3.57% | +100.0% |
| T. Rowe Price Investment Management, Inc. | 2.20M | 3.17% | +100.0% |
| ARK Investment Management, LLC | 1.24M | 1.79% | -9.7% |
| Braidwell LP | 1.08M | 1.56% | +100.0% |
| Alliancebernstein L.P. | 1.00M | 1.44% | +100.0% |
| HHLR Advisors, LTD | 956.46K | 1.38% | +100.0% |
| Artisan Partners Limited Partnership | 932.56K | 1.34% | +52.0% |
| Blackrock Inc. | 896.68K | 1.29% | -1.6% |
| Millennium Management Llc | 865.76K | 1.25% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ALMR
| Fund | Shares | % Held |
|---|---|---|
| ARK ETF Trust-ARK Genomic Revolution ETF | 1.16M | 1.66% |
| ARK Venture Fund | 667.72K | 0.96% |
| AB CAP FUND, INC.-AB Small Cap Growth Portfolio | 587.47K | 0.85% |
| Columbia Funds Series Trust I-Columbia Small Cap Growth Fund | 472.55K | 0.68% |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 355.86K | 0.51% |
| iShares Trust-iShares Russell 2000 ETF | 345.07K | 0.50% |
| Principal Funds, Inc-SmallCap Growth Fund I | 321.12K | 0.46% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 320.26K | 0.46% |
| RBB Fund, Inc.-Emerald Growth Fund | 307.87K | 0.44% |
| Fidelity Select Portfolios-Select Health Care Portfolio | 300.00K | 0.43% |
Frequently asked questions
Who is the largest shareholder of Alamar Biosciences?
Sands Capital Alternatives, LLC is the largest institutional shareholder of ALMR, owning 6.09% of shares outstanding (4.23M shares) as of its latest 13F filing.
What percentage of Alamar Biosciences is owned by institutions?
Institutions own about 58.9% of ALMR shares and 75.8% of the public float.
How much of Alamar Biosciences do insiders own?
Insiders, such as officers and directors, own about 22.29% of ALMR shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.